Company InformationMessage from the President

 

Message from the President

Contributing to people’s health with MAGOKORO (sincerity)

Toshiya Sawai, President & Representative Director

Founded in 1951, we are currently, as a member of the Nipro Group, committed to the contract manufacture of oral solid dosage forms of pharmaceutical products, including formulation development and manufacture of investigational drugs and commercial products.

With our primary mission of stably supplying high-quality pharmaceutical products, based on our management philosophy of “Contributing to people’s health with MAGOKORO (sincerity)”, we have pursued manufacture of distinctive pharmaceutical products and development of more advanced technologies. Especially in terms of quality, we continue our efforts for strengthening our own education and quality assurance systems, based on our Quality Policy and annual quality targets, and continue to supply our products that can be used safely and with peace of mind by patients and medical professionals. To that end, we promise that every employee will carry out each daily work with a strong sense of responsibility and mission to manufacture pharmaceutical products that are directly related to people’s lives and health.

While the business environment surrounding our company changes rapidly, we strive to become a good partner of choice as a CMO/CDMO winning the trust of our valued customers through our continuous efforts to promote further system improvement and stably supply high-quality pharmaceutical products.

We look forward to your continued support and guidance.

 

© 2024 Zensei Pharmaceutical Co., Ltd. All Rights Reserved.

Contact Us